Showing 261-280 of 642 for: Cochrane Systematic Reviews > Cardiovascular 
- Graduated compression stockings for the initial treatment of varicose veins in people without venous ulceration
Cochrane Systematic Reviews, 16-Jul-2021
Compression hosiery or stockings are often the first line of treatment for varicose veins in people without either healed or active venous ulceration. Evidence is required to determine whether the use of compression stockings can effectively manage and tr
- Graft type for femoro‐popliteal bypass surgery
Cochrane Systematic Reviews, 11-Feb-2018
Femoro-popliteal bypass is implemented to save limbs that might otherwise require amputation, in patients with ischaemic rest pain or tissue loss; and to improve walking distance in patients with severe life-limiting claudication. Contemporary practice in
- Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections
Cochrane Systematic Reviews, 15-Aug-2013
Granulocyte-colony stimulating factor (G-CSF) increases the release of neutrophil endothelial progenitor cells from the bone marrow and improves neutrophil functions, which are often impaired in people with diabetes.
- H1-antihistamines for the treatment of anaphylaxis with and without shock
Cochrane Systematic Reviews, 29-Jan-2016
Anaphylaxis is an acute systemic allergic reaction, which can be life-threatening. H1-antihistamines are commonly used as an adjuvant therapy in the treatment of anaphylaxis.
- Haemodilution for acute ischaemic stroke
Cochrane Systematic Reviews, 26-Aug-2014
Ischaemic stroke interrupts the flow of blood to part of the brain. Haemodilution is thought to improve the flow of blood to the affected areas of the brain and thus reduce infarct size.
- Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage
Cochrane Systematic Reviews, 9-Aug-2009
Because spontaneous (non-traumatic) intracerebral haemorrhage (ICH) volume influences its outcome and a third of ICHs enlarge by a third within 24 hours of onset, early haemostatic drug therapy might improve outcome. This is an update of a Cochrane review
- Hands-on therapy interventions for upper limb motor dysfunction following stroke
Cochrane Systematic Reviews, 18-Apr-2011
Recent studies have attempted to disaggregate therapeutic intervention packages by looking at the impact of structure and process characteristics of environment upon outcome. However, what is commonly referred to as the 'black box' of therapy has yet to b
- Hawthorn extract for treating chronic heart failure
Cochrane Systematic Reviews, 20-Nov-2013
Hawthorn extract is advocated as an oral treatment option for chronic heart failure. Also, the German Commission E approved the use of extracts of hawthorn leaf with flower in patients suffering from heart failure graded stage II according to the New York
- Heparin for pregnant women with acquired or inherited thrombophilias
Cochrane Systematic Reviews, 8-Aug-2012
Thrombophilias, which are associated with a predisposition to thrombotic events, have been implicated in adverse obstetrical outcomes such as intrauterine growth restriction, stillbirth, severe early onset pre-eclampsia, and placental abruption. Heparin a
- Heparin for prolonging peripheral intravenous catheter use in neonates
Cochrane Systematic Reviews, 14-Jun-2011
Mechanical or infectious complications often necessitate their removal and/or replacement of peripheral intravenous catheters. Heparin has been shown to be effective in prolonging the patency of peripheral arterial catheters and central venous catheters,
- Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)
Cochrane Systematic Reviews, 7-May-2014
Venous thromboembolic disease has been extensively studied in surgical patients. The benefit of thromboprophylaxis is now generally accepted, but it is medical patients who make up the greater proportion of the hospital population. Medical patients differ
- Heparin versus placebo for non-ST elevation acute coronary syndromes
Cochrane Systematic Reviews, 24-Jun-2014
Non-ST elevation acute coronary syndromes (NSTEACS) represent a spectrum of disease including unstable angina and non-ST segment myocardial infarction (NSTEMI). Despite treatment with aspirin, beta-blockers and nitroglycerin, unstable angina/NSTEMI is sti
- Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures
Cochrane Systematic Reviews, 10-Aug-2008
Hip fracture patients have a high risk of thrombo-embolic complications following surgical management.
- Heparin-bonded catheters for prolonging the patency of central venous catheters in children
Cochrane Systematic Reviews, 25-Feb-2014
Central venous catheters (CVCs) are a mainstay in the management of critically ill children. However, these catheters are associated with mechanical and infectious complications which reduce their life span. Heparin bonding of catheters has shown promise
- Heparins and mechanical methods for thromboprophylaxis in colorectal surgery
Cochrane Systematic Reviews, 23-Jul-2008
Colorectal surgery implies higher risk of postoperative thromboembolic complications as deep venous thrombosis (DVT) and pulmonary embolism (PE) than general surgery. The best prophylaxis in general surgery is heparin and graded compression stockings. No
- Herbal medicines for viral myocarditis
Cochrane Systematic Reviews, 28-Aug-2013
Herbal medicines are used as treatment for viral diseases such as viral myocarditis, and numerous clinical trials have been conducted to investigate their efficacy. Despite this wealth of evidence, the role of herbal medicines in the treatment of viral my
- HMG CoA reductase inhibitors (statins) for dialysis patients
Cochrane Systematic Reviews, 2-Sep-2013
People with advanced kidney disease treated with dialysis experience mortality rates from cardiovascular disease that are substantially higher than for the general population. Studies that have assessed the benefits of statins (HMG CoA reductase inhibitor
- HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Cochrane Systematic Reviews, 8-Jul-2014
Cardiovascular disease (CVD) is the most frequent cause of death in people with early stages of chronic kidney disease (CKD), for whom the absolute risk of cardiovascular events is similar to people who have existing coronary artery disease. This is an up
- Home versus in-patient treatment for deep vein thrombosis
Cochrane Systematic Reviews, 13-Feb-2011
Deep vein thrombosis (DVT) occurs when a blood clot blocks blood flow through a vein. This can happen after surgery, trauma, or when a person has been immobile. Clots can dislodge and block blood flow to the lungs, causing death. Heparin is a blood-thinni
- Home-based therapy programmes for upper limb functional recovery following stroke
Cochrane Systematic Reviews, 17-Apr-2012
With an increased focus on home-based stroke services and the undertaking of programmes, targeted at upper limb recovery within clinical practice, a systematic review of home-based therapy programmes for individuals with upper limb impairment following st
